U.S. Electrical Stock News

Hawaiian Electric Industries (NYSE:HE) has agreed to a $100 million settlement to resolve significant stockholder derivative lawsuits. The payment will be funded by insurers and also partially settles a related securities class action. The agreement is subject to final court approval, with upcoming hearings expected to clarify the remaining legal process. For shareholders watching NYSE:HE at a current share price of $14.67, this settlement addresses a key source of legal uncertainty. The...

Curious if Union Pacific at around US$238.79 is offering fair value or a margin of safety right now? This article walks through the key numbers that matter for you. The stock has seen mixed returns recently, with a 0.2% move over the last 7 days, a 9.9% decline over 30 days, gains of 3.0% year to date and 3.5% over the last year, and gains of 28.2% over 3 years and 19.6% over 5 years. Recent coverage of Union Pacific has focused on its role as a major U.S. railroad operator and how broader...

Xcel Energy (NasdaqGS:XEL) has filed new regulatory materials with the Federal Energy Regulatory Commission focused on dam safety and compliance. The company’s recent correspondence covers dam stability, embankment integrity, and landslide monitoring at its hydro-related facilities. These filings outline ongoing safety measures and responses to federal oversight of critical infrastructure. Xcel Energy, a regulated electric and natural gas utility, depends on reliable generation and...

If you are wondering whether Viavi Solutions at US$34.64 is still attractively priced after a big run, the key question is what that price actually reflects about the business. The stock has delivered returns of 3.1% over the past week, 16.6% over the past month, 90.9% year to date and 209.6% over the last year, with a 225.3% return over three years and 114.0% over five years, which puts recent valuation questions front and center. Recent coverage has focused on Viavi Solutions as a...

Palvella Therapeutics (NasdaqCM:PVLA) has appointed Jennifer J. McDonough as Senior Vice President of Market Access and Patient Services. McDonough has extensive experience launching and commercializing therapies for rare skin diseases, including work on VYJUVEK®. The appointment is intended to support Palvella’s commercial readiness as QTORIN™ rapamycin advances through late-stage trials. For investors watching rare disease drug developers, Palvella Therapeutics sits at the intersection of...

In the past week, Best Buy reported quarterly results showing adjusted EPS of US$2.61, up 1.2% year over year, alongside a 0.8% decline in comparable sales and slightly softer-than-expected revenue, while also announcing a 1% increase in its quarterly dividend to US$0.96 per share. Management’s decision to raise the dividend and emphasize scalable profit drivers such as its digital Marketplace and Best Buy Ads highlights a focus on recurring, higher-margin revenue streams even as top-line...

If you are wondering whether Cal-Maine Foods at around US$77.12 is pricing in too much optimism or leaving some value on the table, a closer look at its valuation can help frame that question. The share price is near US$77.12 after a 0.1% move over the last 7 days, with an 11.5% decline over 30 days, a 1.7% decline year to date, a 7.8% decline over 1 year, but a 53.8% gain over 3 years and a 159.0% gain over 5 years. Recent coverage has focused on Cal-Maine Foods as a key player in the US...

Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Morningstar...

What stands out about Stock Yards Bancorp right now Stock Yards Bancorp (SYBT) has drawn attention after recent trading left the shares around $63.91, with returns showing small single digit moves over the past week, month, and past 3 months. See our latest analysis for Stock Yards Bancorp. While the 1 day share price return of 2.31% and year to date share price return of 1.98% are both negative, the 3 year total shareholder return of 24.86% and 5 year total shareholder return of 37.15%...

Wondering whether CVS Health at around US$70 still offers value, or if the easy money has already been made? This article walks through the key numbers so you can judge for yourself. The stock is around US$70.08 after a 1.7% decline over the past week and double digit declines of 12.3% for the past month and 12.5% year to date, even though the 1 year return sits at 7.4% and the 3 and 5 year returns are 3.4% and 10.0% respectively. Recent headlines around CVS Health have focused on its role...

Western Digital joined an open source quantum error correction initiative with Open Quantum Design and QuScript, targeting more reliable quantum computing. The collaboration focuses on setting shared standards and protocols for fault tolerant quantum systems. The move expands Western Digital's role beyond storage into quantum computing reliability and system level error correction. Western Digital (NasdaqGS:WDC) enters this partnership with a share price of $275.34 and very large 1 year and...

Burford Capital recently reported that the US Court of Appeals for the Second Circuit reversed the prior District Court judgment in favor of Petersen and Eton Park in the long-running YPF litigation, prompting the company to review the case’s carrying value and consider a potentially material asset write-down in its upcoming first-quarter results. This reversal directly affects a case that represents a large share of Burford’s fair value assets, underscoring how concentrated legal exposures...

In March 2026, VNET Group, Inc. reported that fourth-quarter 2025 sales rose to CNY 2,687.09 million and net income reached CNY 304.67 million, reversing a net loss a year earlier, while full-year 2025 sales increased to CNY 9,949.26 million despite a net loss of CNY 251.84 million. The company also issued full-year 2026 guidance calling for total net revenues of RMB 11.5–11.8 billion, highlighting management’s confidence in sustaining double-digit growth in its data center business despite...

AnaptysBio has approved the spin off of First Tracks Biotherapeutics, with shareholders set to receive one First Tracks share for each AnaptysBio share held. First Tracks Biotherapeutics is expected to list on Nasdaq and will be funded through capital from AnaptysBio and a private placement. The company has added experienced industry executive Susannah Gray to its board as part of the transition. The spin off comes as AnaptysBio, listed as NasdaqGS:ANAB, is in focus with a current share...

Wondering if DocuSign at around US$45.71 is a bargain or still pricing in big expectations? This article walks through what the current share price might be implying about value. The stock has had a mixed run, with a 1.4% return over 30 days, a 29.5% decline year to date, and a 43.8% decline over the last year. These moves can change how the market views both risk and potential reward. Recent coverage has focused on DocuSign's position in digital agreements and how investors are reassessing...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with anticipated earnings growth of 15% annually in the coming years. In this dynamic environment, identifying promising small-cap stocks with insider buying can offer unique opportunities for investors seeking potential value amidst fluctuating market conditions.

Over the last 7 days, the United States market has dropped 1.9%, yet it has risen by 15% over the past year, with earnings forecast to grow annually by the same percentage. In this context of fluctuating short-term performance and promising long-term growth prospects, identifying high-growth tech stocks can be a strategic approach for investors looking to capitalize on innovation-driven sectors.

Recent commentary on A. O. Smith highlights that the water heater and treatment manufacturer has faced end‑market headwinds, with sales broadly flat and earnings per share growing more slowly than peers over the past two years. Analysts also point to weakening returns on capital, suggesting that some of A. O. Smith’s historically profitable areas may now be delivering less incremental benefit. We’ll now examine how persistent end‑market challenges, particularly flat sales, may influence A...

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In such conditions, identifying stocks that may be trading below their intrinsic value can present potential opportunities for investors seeking to capitalize on undervalued assets in a growing market.

Over the last 7 days, the United States market has experienced a 1.9% decline, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually. In this environment, identifying growth companies with high insider ownership can be advantageous as they often signal confidence in long-term prospects and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped 1.9%, while showing a notable 15% rise over the past year, with earnings expected to grow annually by the same percentage. In such a fluctuating market, identifying stocks with strong fundamentals and growth potential becomes crucial for investors seeking stability and opportunity. Penny stocks, though an older term, still signify smaller or emerging companies that can offer significant value; when these companies have solid...

Icahn Enterprises (IEP) has drawn fresh attention after recent trading left the units at a last close of US$7.45, with returns mixed across recent periods and a value score of 4 catching investor interest. See our latest analysis for Icahn Enterprises. Recent trading has been soft, with a 1 day share price return of 2.74% and a 30 day share price return of 7.57%. The 1 year total shareholder return of 3.47% contrasts with a 3 year total shareholder return of 72.93% and a 5 year total...

The United States market has experienced a 1.9% decline over the last week, yet it remains up by 15% over the past year, with earnings projected to grow annually by 15%. In this dynamic environment, identifying stocks like Seneca Foods that offer unique value propositions and growth potential can be key to uncovering hidden opportunities.

Over the last 7 days, the United States market has experienced a 1.9% drop, although it has risen by 15% over the past year with earnings expected to grow annually by the same percentage. In this fluctuating environment, dividend stocks can offer stability and income potential for investors seeking consistent returns amidst market volatility.